Amadeus Capital Partners is an investor backing trailblazers solving hard problems across intelligence, human, and planet technology areas from seed to growth stages.
Novalis LifeSciences led the Series B round, which will fund team expansion and platform commercialisation.
"Our mission as a company is to enable widespread patient access to life saving cell and gene therapies. One of the biggest obstacles to achieving this is cell and gene therapy manufacturing processes that are too expensive, too highly variable and too low throughput. Our team is focused on the urgent need to enhance the ability of cell and gene therapy developers, CDMOs and Academic Medical Centers to deliver these therapies to as many patients as possible as quickly as possible,"
AlbionVC leads the latest funding round alongside existing backers Amadeus Capital Partners and Finch Capital.
"Organisations that can extract insights from big data in a timely manner will be the leaders of tomorrow. Our investment in Brytlyt.io is in firm support of that thesis. We are therefore delighted to welcome Brytlyt.io, and visionary founder Richard, into our growing portfolio of cutting-edge data companies that includes Quantexa, Solidatus, Elliptic and more"
Turquoise led the seed round with participation from Cambridge Agritech, Deeptech Labs, and Amadeus to support international expansion.
"We are delighted to welcome LCIF2 as an investor in Outfield. This investment will enable us to develop the customer base as well as adding new functionalities to the platform. Now is the time for new precision technologies to revolutionise this sector, supporting global food security and managing the environmental impacts of fruit growing"
The financing round was led by Octopus Ventures with backing from both new and existing investors.
"Today, we’ve developed the world’s first Engineering-Grade AR solution helping construction teams identify errors in real-time, but really that’s just the start of our journey. The next phase is Assisted Reality, where our spatial computing technology will have the intelligence to automatically detect and report issues in the field. And ultimately, the goal is builders building from holograms. Our vision of developing world changing products aligns with Octopus Ventures’ mission of investing in companies that are powering the next industrial revolution. We look forward to building history."
KEEN Venture Partners led the Series A follow-on round, with backing from existing investors and Tom Teichman.
"Doctify co-founders Stephanie and Suman, both surgeons by background, bring deep expertise in healthcare and are in prime position to transform and win the market. Their solution is driving real-time improvements to patient care across multiple international providers."
